申联生物：子公司取得《兽药GMP证书》和《兽药生产许可证》

Core Viewpoint - The company has successfully passed the veterinary drug GMP acceptance and obtained the relevant certificates, enhancing its production capabilities and accelerating the launch of new vaccines [1] Group 1: Certification Achievements - The company's Lanzhou branch has received the Veterinary Drug GMP Certificate (Certificate No.: (2026) Veterinary Drug GMP Certificate No. 28001) and the Veterinary Production License (Certificate No.: Veterinary Production License No. 28018) from the Gansu Provincial Department of Agriculture and Rural Affairs [1] - Both certificates are valid from January 14, 2026, to January 13, 2031, indicating a long-term compliance with regulatory standards [1] Group 2: Production Capabilities - The certification signifies that the company's production lines for cell suspension culture viral live vaccines and bacterial live vaccines are officially qualified for production [1] - This development will help diversify the product range, enhance production capacity, and expedite the process of bringing new vaccines to market [1]